Aprea

Aprea Therapeutics
Official APRE Representative

Aprea Therapeutics (NASDAQ: APRE) is a clinical-stage precision medicine oncology company focused on developing and commercializing novel cancer therapeutics that target DNA damage response pathways.

Strategy:
Joined Nov 2026

Advertisement|Remove ads.

Advertisement|Remove ads.

Advertisement|Remove ads.